Free Trial
OTCMKTS:TINLY

Teijin 8/7/2023 Earnings Report

Teijin logo
$8.30 0.00 (0.00%)
As of 07/14/2025

Teijin EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Teijin Revenue Results

Actual Revenue
$1.78 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Teijin Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Teijin's next earnings date is estimated for Sunday, August 3, 2025, based on past reporting schedules.

Conference Call Resources

Teijin Earnings Headlines

[ATTENTION] This Crypto Rocket Is About Launch…
Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.
See More Teijin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Teijin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teijin and other key companies, straight to your email.

About Teijin

Teijin (OTCMKTS:TINLY) Limited is a diversified Japanese conglomerate specializing in advanced materials, healthcare, and information technology solutions. Originally founded in 1918 as Teikoku Jinzo Kabushiki Kaisha to produce rayon, the company evolved over the decades into a global provider of high-performance fibers, composites, resin and plastic processing, and films. Teijin’s materials division is renowned for its production of aramid fibers under the Twaron and Technora brands, carbon fiber composites for aerospace and automotive applications, and polyester films used in electronics and coatings.

In addition to its materials business, Teijin operates a healthcare segment that develops pharmaceuticals, home healthcare equipment, and regenerative medicine products. The company’s pharmaceutical arm focuses on treatments for thrombosis and cardiovascular diseases, while its medical device division offers orthopedic and diagnostic solutions. Teijin also leverages its expertise in polymers and biomaterials to provide memory foam and protective textiles, catering to sectors such as personal protective equipment and sportswear.

Teijin maintains a strong international presence, with manufacturing sites and research centers across Asia, Europe, and North America. The company serves industries ranging from aerospace and automotive to electronics and healthcare, collaborating with major OEMs and research institutions to drive innovation in lightweight composites and sustainable materials. Teijin’s global network supports localized production and distribution, enabling it to respond to regional market needs and strengthen supply chain resilience.

Under the leadership of President and CEO Masahiro Okafuji, supported by a board chaired by Naoki Ishii, Teijin emphasizes sustainable growth, circular economy initiatives, and digital transformation. The company has set strategic goals to enhance resource efficiency, reduce environmental impact, and expand its portfolio of eco-friendly products. Through continuous investment in research and development, Teijin strives to deliver advanced solutions that address societal challenges such as climate change, aging populations, and the demand for safer, lighter, and more durable materials.

View Teijin Profile

More Earnings Resources from MarketBeat